South Korea's top 100 firms exhibited a combined market value of 1,745 trillion won on Thursday, up 77.5 percent from 983 trillion won five years ago amid a recent stock market rally.
According to the data from market researcher CXO Institute, the latest tally was a 43.1 percent increase from last year.
Samsung Electronics Co. remains the top-cap South Korean company with 495.5 trillion won, followed by SK hynix Inc. with 91.7 trillion won, and LG Chem Ltd. with 62.8 trillion won.
The highest on-year growth rate among the 100 firms was shown by Shinpoong Pharmaceutical Co., whose market value shoot up 1,567 percent on-year to 6.5 trillion won this year.
New entrants to the top 100 list include SK Biopharmaceuticals Co., Big Hit Entertainment, and Kakao Games Corp. The three firms made a blockbuster debut on the local bourse last year.
The South Korean stock market has been on a roll in recent months due to a growing optimism over an economic recovery.


Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Iran-U.S. Conflict Escalation Threatens Global Oil Supply and Economic Stability
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Gold Prices Dip Ahead of Fed Decision Amid Rising Middle East Tensions
China Manufacturing PMI Beats Forecasts in April Amid Weak Domestic Demand
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Tokyo Inflation Slows Despite Energy Pressures and BOJ Policy Outlook
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Oil Prices Ease but Remain Set for Strong April Gains Amid Middle East Tensions
US Stock Futures Rise as S&P 500 and Nasdaq Hit Record Highs Amid Earnings Optimism and Iran Tensions
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Markets Stay Strong Despite Oil Shock Concerns as Earnings Drive Investor Confidence
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 



